To summarize, our study demonstrated that AHSG promotes the proliferation of bladder cancer cells by regulating the TGF-β signaling pathway, thereby promoting bladder cancer progression, suggesting that AHSG may be a potential target for clinical diagnosis and treatment of bladder cancer. Here, TGFB1 is linked to urinary bladder cancer.